Screening compound: C17H19ClN2S (6264-0421)

Screening compound: C<sub>17</sub>H<sub>19</sub>ClN<sub>2</sub>S (6264-0421)
Screening compound: C<sub>17</sub>H<sub>19</sub>ClN<sub>2</sub>S (6264-0421) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C17H19ClN2S (6264-0421)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

6264-0421

Molecular Formula

C17H19ClN2S (C17 H19 ClN2 S)

Compound Name

[3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine

IUPAC name

[3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine

SMILES

CN(C)CCCN1c(cc(cc2)Cl)c2Sc2c1cccc2

MDL Number (MFCD)

C17H19ClN2S (6264-0421) in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Anti-infective Library (19449 compounds)

Anticancer Library (62698 compounds)

Antiparasite Library (23996 compounds)

Antiviral Annotated Library (21441 compounds)

Antiviral Library (67538 compounds)

CNS Annotated Library (688 compounds)

CNS targets activity set (6557 compounds)

Human GPCR Annotated Library (5539 compounds)

Human Ion Channels Annotated Library (353 compounds)

Human Receptors Annotated Library (5376 compounds)

Launched & Clinically Evaluated Drugs Library (185 compounds)

Nucleic Acid Ligands (8311 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Targeted Diversity Library (40567 compounds)

Therapeutical Diversity Annotated Library (7563 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

Akt-Targeted Library (14764 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Cancer
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • Epigenetic
Agro:
  • Agro
Targets:
  • Kinases
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with C17H19ClN2S (6264-0421) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C17H19ClN2S (6264-0421)?
Check Price and Availability of C17H19ClN2S (6264-0421), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C17H19ClN2S (6264-0421) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C17H19ClN2S (6264-0421)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C17H19ClN2S (6264-0421)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C17H19ClN2S (6264-0421) available by request